“Tapinarof Cream 1% Once Daily: Disease Control Off Treatment and Minimal Disease Activity Through End of Remittive Period in a 1-Year Trial”. 2023. SKIN The Journal of Cutaneous Medicine 7 (2): s125. https://doi.org/10.25251/skin.7.supp.125.